{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T15:03:39Z","timestamp":1782831819439,"version":"3.54.5"},"reference-count":213,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lab Anim Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Inflammatory bowel disease (IBD) represents a group of chronic inflammatory conditions that extend beyond the gastrointestinal tract, with profound systemic effects on the musculoskeletal system. This review comprehensively examines the experimental models that have elucidated the intricate relationship between intestinal inflammation and the development of osteosarcopenia\u2014the concurrent deterioration of bone and muscle tissues. We analyze chemically-induced models (DSS, TNBS), genetically engineered models (T-cell transfer, IL-10 knockout, IL-2 knockout), and the Winnie mouse model of spontaneous colitis, highlighting their contributions to our understanding of IBD-associated musculoskeletal complications. The review emphasizes how these models have revealed critical molecular mediators, particularly gut-derived serotonin and vitamin D signaling pathways, that connect intestinal pathology to distant skeletal deterioration. Notably, pro-inflammatory cytokines including TNF-\u03b1, IL-6, and IL-17 emerge as central regulators affecting both bone and muscle homeostasis, explaining the synchronized pattern of deterioration observed clinically. The findings from these experimental models highlight potential therapeutic targets and intervention strategies beyond conventional approaches, including gut-derived serotonin inhibition and vitamin D modulation. This review underscores the value of chronic colitis models in elucidating the complex pathophysiology of IBD-associated osteosarcopenia and provides direction for translational research to develop integrated treatment approaches for this debilitating extraintestinal manifestation.<\/jats:p>","DOI":"10.1186\/s42826-026-00273-x","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T03:07:03Z","timestamp":1776136023000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Cross-talk of gut-bone-muscle: osteosarcopenia in experimental colitis models"],"prefix":"10.1186","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7292-1242","authenticated-orcid":false,"given":"Shilpa","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,14]]},"reference":[{"issue":"1","key":"273_CR1","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1038\/modpathol.2014.131","volume":"28","author":"RD Odze","year":"2015","unstructured":"Odze RD. A contemporary and critical appraisal of \u2018indeterminate colitis\u2019. Mod Pathol. 2015;28(1):S30\u201346.","journal-title":"Mod Pathol"},{"key":"273_CR2","doi-asserted-by":"crossref","unstructured":"Aniwan S, Santiago P, Loftus EV Jr, Park SH. The epidemiology of inflammatory bowel disease in Asia and Asian immigrants to Western countries. United Eur Gastroenterol J. 2022;10(10):1063\u201376.","DOI":"10.1002\/ueg2.12350"},{"key":"273_CR3","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1146\/annurev-immunol-030409-101225","volume":"28","author":"A Kaser","year":"2010","unstructured":"Kaser A, Zeissig S, Blumberg RS. Inflammatory bowel disease. Annu Rev Immunol. 2010;28:573\u2013621.","journal-title":"Annu Rev Immunol"},{"key":"273_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/2058738419866567","volume":"33","author":"S Chams","year":"2019","unstructured":"Chams S, Badran R, Sayegh S, El, Chams N, Shams A, Hussein IH. Inflammatory bowel disease: Looking beyond the tract. Int J Immunopathol Pharmacol. 2019;33:1\u201318.","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"35","key":"273_CR5","doi-asserted-by":"publisher","first-page":"5362","DOI":"10.3748\/wjg.v26.i35.5362","volume":"26","author":"S K\u00e4rnsund","year":"2020","unstructured":"K\u00e4rnsund S, Lo B, Bendtsen F, Holm J, Burisch J. Systematic review of the prevalence and development of osteoporosis or low bone mineral density and its risk factors in patients with inflammatory bowel disease. World J Gastroenterol. 2020;26(35):5362\u201374.","journal-title":"World J Gastroenterol"},{"issue":"4","key":"273_CR6","first-page":"296","volume":"26","author":"P Miheller","year":"2013","unstructured":"Miheller P, Gesztes W, Lakatos PL. Manipulating bone disease in inflammatory bowel disease patients. Ann Gastroenterol. 2013;26(4):296\u2013303.","journal-title":"Ann Gastroenterol"},{"key":"273_CR7","doi-asserted-by":"crossref","unstructured":"Kreienbuehl AS, Rogler G, Burri E, Biedermann L, Meier C, Juillerat P, et al. Bone health in patients with inflammatory bowel disease. Swiss Med Wkly. 2024;154(6).","DOI":"10.57187\/s.3407"},{"issue":"3","key":"273_CR8","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1007\/s11938-022-00389-8","volume":"20","author":"AS Faye","year":"2022","unstructured":"Faye AS, Khan T, Cautha S, Kochar B. Sarcopenia in Inflammatory Bowel Diseases: Reviewing Past Work to Pave the Path for the Future. Curr Treat Options Gastroenterol. 2022;20(3):250\u201360.","journal-title":"Curr Treat Options Gastroenterol"},{"issue":"3","key":"273_CR9","doi-asserted-by":"publisher","first-page":"254","DOI":"10.5217\/ir.2024.00185","volume":"23","author":"S Sharma","year":"2025","unstructured":"Sharma S, Gut. Bone, and Muscle: The triad of osteosarcopenia in inflammatory bowel disease. Intest Res. 2025;23(3):254\u201389.","journal-title":"Intest Res"},{"issue":"2","key":"273_CR10","doi-asserted-by":"publisher","first-page":"289","DOI":"10.3390\/biomedicines10020289","volume":"10","author":"C Stolfi","year":"2022","unstructured":"Stolfi C, Maresca C, Monteleone G, Laudisi F. Implication of intestinal barrier dysfunction in gut dysbiosis and diseases. Biomedicines. 2022;10(2):289.","journal-title":"Biomedicines"},{"issue":"6","key":"273_CR11","doi-asserted-by":"publisher","first-page":"544","DOI":"10.4161\/gmic.22156","volume":"3","author":"G Loh","year":"2012","unstructured":"Loh G, Blaut M. Role of commensal gut bacteria in inflammatory bowel diseases. Gut Microbes. 2012;3(6):544\u201355.","journal-title":"Gut Microbes"},{"key":"273_CR12","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.3389\/fimmu.2021.694217","volume":"12","author":"OM Nardone","year":"2021","unstructured":"Nardone OM, de Sire R, Petito V, Testa A, Villani G, Scaldaferri F, et al. Inflammatory bowel diseases and sarcopenia: the role of inflammation and gut microbiota in the development of muscle Failure. Front Immunol. 2021;12:694217.","journal-title":"Front Immunol"},{"issue":"10","key":"273_CR13","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nrgastro.2017.88","volume":"14","author":"J Ni","year":"2017","unstructured":"Ni J, Wu GD, Albenberg L, Tomov VT. Gut microbiota and IBD: Causation or correlation? Nat Rev Gastroenterol Hepatol. 2017;14(10):573\u201384.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"273_CR14","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.intimp.2017.07.023","volume":"51","author":"C Lee","year":"2017","unstructured":"Lee C, Kim BG, Kim JH, Chun J, Im JP, Kim JS. Sodium butyrate inhibits the NF-kappa B signaling pathway and histone deacetylation, and attenuates experimental colitis in an IL-10 independent manner. Int Immunopharmacol. 2017;51:47\u201356.","journal-title":"Int Immunopharmacol"},{"issue":"6","key":"273_CR15","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.immuni.2018.10.013","volume":"49","author":"AM Tyagi","year":"2018","unstructured":"Tyagi AM, Yu M, Darby TM, Vaccaro C, Li J-Y, Owens JA, et al. The Microbial Metabolite Butyrate Stimulates Bone Formation via T Regulatory Cell-Mediated Regulation of WNT10B Expression. Immunity. 2018;49(6):1116\u2013e11317.","journal-title":"Immunity"},{"key":"273_CR16","doi-asserted-by":"crossref","unstructured":"Facchin S, Bertin L, Bonazzi E, Lorenzon G, De Barba C, Barberio B, et al. Short-chain fatty acids and human health: from metabolic pathways to current therapeutic implications. Life. 2024;14.","DOI":"10.20944\/preprints202403.1638.v1"},{"issue":"2","key":"273_CR17","doi-asserted-by":"publisher","first-page":"2263207","DOI":"10.1080\/19490976.2023.2263207","volume":"15","author":"Y Wang","year":"2023","unstructured":"Wang Y, Li Y, Bo L, Zhou E, Chen Y, Naranmandakh S, et al. Progress of linking gut microbiota and musculoskeletal health: casualty, mechanisms, and translational values. Gut Microbes. 2023;15(2):2263207.","journal-title":"Gut Microbes"},{"issue":"1","key":"273_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11357-024-01451-2","volume":"47","author":"J Escalante","year":"2025","unstructured":"Escalante J, Artaiz O, Diwakarla S, McQuade RM. Leaky gut in systemic inflammation: exploring the link between gastrointestinal disorders and age-related diseases. GeroScience. 2025;47(1):1\u201322.","journal-title":"GeroScience"},{"key":"273_CR19","doi-asserted-by":"crossref","unstructured":"Ghosh SS, Wang J, Yannie PJ, Ghosh S. Intestinal barrier dysfunction, LPS translocation, and disease development. J Endocr Soc. 2020;4(2):bvz039.","DOI":"10.1210\/jendso\/bvz039"},{"key":"273_CR20","doi-asserted-by":"crossref","unstructured":"Jang SY, Choi KM. Bidirectional crosstalk between bone and muscle: the role of RANKL pathway in osteosarcopenia. J Endocrinol. 2024;262(3):e240093.","DOI":"10.1530\/JOE-24-0093"},{"issue":"8","key":"273_CR21","doi-asserted-by":"publisher","first-page":"C663","DOI":"10.1152\/ajpcell.00285.2015","volume":"310","author":"SS Dufresne","year":"2016","unstructured":"Dufresne SS, Dumont NA, Boulanger-Piette A, Fajardo VA, Gamu D, Kake-Guena S-A, et al. Muscle RANK is a key regulator of Ca2\u2009+\u2009storage, SERCA activity, and function of fast-twitch skeletal muscles. Am J Physiol Cell Physiol. 2016;310(8):C663\u201372.","journal-title":"Am J Physiol Cell Physiol"},{"key":"273_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphys.2022.1032450","volume":"13","author":"Z Bouredji","year":"2022","unstructured":"Bouredji Z, Argaw A, Frenette J. The inflammatory response, a mixed blessing for muscle homeostasis and plasticity. Front Physiol. 2022;13:1\u201316.","journal-title":"Front Physiol"},{"key":"273_CR23","doi-asserted-by":"crossref","unstructured":"Gostage J, Kostenuik P, Goljanek K, Bellantuono I, Mccloskey E. Extra \u2013 osseous roles of the RANK \u2013 RANKL \u2013 OPG axis with a focus on skeletal muscle modifications on muscle mass. Curr Osteoporos Rep. 2024;22(6):632\u201350.","DOI":"10.1007\/s11914-024-00890-2"},{"issue":"6","key":"273_CR24","doi-asserted-by":"publisher","first-page":"E469","DOI":"10.1152\/ajpendo.00204.2014","volume":"307","author":"SC Bodine","year":"2014","unstructured":"Bodine SC, Baehr LM. Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx\/atrogin-1. Am J Physiol Endocrinol Metab. 2014;307(6):E469\u201384.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"273_CR25","first-page":"36","volume":"43","author":"R Sheng","year":"2023","unstructured":"Sheng R, Cao M, Song M, Wang M, Zhang Y, Shi L, et al. Muscle-bone crosstalk via endocrine signals and potential targets for osteosarcopenia-related fracture. J Orthop Transl. 2023;43:36\u201346.","journal-title":"J Orthop Transl"},{"key":"273_CR26","doi-asserted-by":"crossref","unstructured":"Skrzypczak D, Ratajczak AE, Szymczak-Tomczak A, Dobrowolska A, Eder P, Krela-Ka\u017amierczak I. A vicious cycle of osteosarcopenia in inflammatory bowel diseases\u2014aetiology, clinical implications and therapeutic perspectives. Nutrients. 2021;13:293.","DOI":"10.3390\/nu13020293"},{"issue":"2","key":"273_CR27","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.jcmgh.2015.01.006","volume":"1","author":"P Kiesler","year":"2015","unstructured":"Kiesler P, Fuss IJ, Strober W. Experimental models of inflammatory bowel diseases. Cell Mol Gastroenterol Hepatol. 2015;1(2):154\u201370.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"2","key":"273_CR28","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3892\/ijmm.2013.1569","volume":"33","author":"CK-A Oh","year":"2014","unstructured":"Oh CK-A, Kang JL, Kim KH, Woo S-Y. Comparison of experimental mouse models of inflammatory bowel disease. Int J Mol Med. 2014;33(2):333\u201340.","journal-title":"Int J Mol Med"},{"issue":"24","key":"273_CR29","doi-asserted-by":"publisher","first-page":"6323","DOI":"10.3390\/ijms20246323","volume":"20","author":"K Ke","year":"2019","unstructured":"Ke K, Arra M, Abu-Amer Y. Mechanisms Underlying Bone Loss Associated with Gut Inflammation. Int J Mol Sci. 2019;20(24):6323.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"273_CR30","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.bone.2008.06.018","volume":"43","author":"G Hamdani","year":"2008","unstructured":"Hamdani G, Gabet Y, Rachmilewitz D, Karmeli F, Bab I, Dresner-Pollak R. Dextran sodium sulfate-induced colitis causes rapid bone loss in mice. Bone. 2008;43(5):945\u201350.","journal-title":"Bone"},{"issue":"5","key":"273_CR31","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1152\/ajpgi.90696.2008","volume":"296","author":"L Harris","year":"2009","unstructured":"Harris L, Senagore P, Young VB, McCabe LR. Inflammatory bowel disease causes reversible suppression of osteoblast and chondrocyte function in mice. Am J Physiol - Gastrointest Liver Physiol. 2009;296(5):1020\u20139.","journal-title":"Am J Physiol - Gastrointest Liver Physiol"},{"key":"273_CR32","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1152\/ajpregu.00051.2016","volume":"311","author":"R Irwin","year":"2016","unstructured":"Irwin R, Raehtz S, Parameswaran N, Mccabe XLR. Intestinal inflammation without weight loss decreases bone density and growth. Am J Physiol Regul Integr Comp Physiol. 2016;311:1149\u201357.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"1","key":"273_CR33","doi-asserted-by":"publisher","first-page":"15144","DOI":"10.1038\/s41598-019-51550-w","volume":"9","author":"CE Metzger","year":"2019","unstructured":"Metzger CE, Narayanan SA, Elizondo JP, Carter AM, Zawieja DC, Hogan HA, et al. DSS-induced colitis produces inflammation-induced bone loss while irisin treatment mitigates the inflammatory state in both gut and bone. Sci Rep. 2019;9(1):15144.","journal-title":"Sci Rep"},{"issue":"5","key":"273_CR34","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/pr.2016.135","volume":"80","author":"P Vassilyadi","year":"2016","unstructured":"Vassilyadi P, Harding SV, Hazell TJ, Weiler HA, Wykes LJ. Colitis, independent of macronutrient intake, compromises bone structure and strength in growing piglets. Pediatr Res. 2016;80(5):753\u20138.","journal-title":"Pediatr Res"},{"issue":"3","key":"273_CR35","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1203\/PDR.0b013e3181cb8e49","volume":"67","author":"SV Harding","year":"2010","unstructured":"Harding SV, Adegoke OAJ, Fraser KG, Marliss EB, Chevalier S, Kimball SR, et al. Maintaining adequate nutrition, not probiotic administration, prevents growth stunting and maintains skeletal muscle protein synthesis rates in a piglet model of colitis. Pediatr Res. 2010;67(3):268\u201373.","journal-title":"Pediatr Res"},{"issue":"1","key":"273_CR36","first-page":"1","volume":"26","author":"D Saul","year":"2019","unstructured":"Saul D, Kosinsky RL. Dextran Sodium Sulfate-induced Colitis as a Model for Sarcopenia in Mice. Inflamm Bowel Dis. 2019;26(1):1\u201310.","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"273_CR37","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1002\/jcsm.13208","volume":"14","author":"Y-K Jung","year":"2023","unstructured":"Jung Y-K, Lee S, Yoo J-I, Baek K-W. The protective effect of IL-12\/23 neutralizing antibody in sarcopenia associated with dextran sulfate sodium-induced experimental colitis. J Cachexia Sarcopenia Muscle. 2023;14(2):1096\u2013106.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"4","key":"273_CR38","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1002\/jbmr.3027","volume":"32","author":"CE Metzger","year":"2017","unstructured":"Metzger CE, Narayanan A, Zawieja DC, Bloomfield SA. Inflammatory Bowel Disease in a Rodent Model Alters Osteocyte Protein Levels Controlling Bone Turnover. J Bone Min Res. 2017;32(4):802\u201313.","journal-title":"J Bone Min Res"},{"issue":"11","key":"273_CR39","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1016\/j.metabol.2010.03.021","volume":"59","author":"F Puleo","year":"2010","unstructured":"Puleo F, Meirelles K, Navaratnarajah M, Fitzpatrick L, Shumate ML, Cooney RN, et al. Skeletal muscle catabolism in trinitrobenzene sulfonic acid-induced murine colitis. Metabolism. 2010;59(11):1680\u201390.","journal-title":"Metabolism"},{"issue":"1","key":"273_CR40","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1136\/gut.2003.035113","volume":"54","author":"FR Byrne","year":"2005","unstructured":"Byrne FR, Morony S, Warmington K, Geng Z, Brown HL, Flores SA, et al. CD4\u2009+\u2009CD45RBHi T cell transfer induced colitis in mice is accompanied by osteopenia which is treatable with recombinant human osteoprotegerin. Gut. 2005;54(1):78\u201386.","journal-title":"Gut"},{"issue":"2","key":"273_CR41","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1097\/MIB.0000000000000269","volume":"21","author":"K Holgersen","year":"2015","unstructured":"Holgersen K, Dobie R, Farquharson C, van\u2019t Hof R, Ahmed SF, Hansen AK, et al. Piroxicam Treatment Augments Bone Abnormalities in Interleukin-10 Knockout Mice. Inflamm Bowel Dis. 2015;21(2):257\u201366.","journal-title":"Inflamm Bowel Dis"},{"issue":"8","key":"273_CR42","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1097\/MIB.0b013e318289e17b","volume":"19","author":"R Irwin","year":"2013","unstructured":"Irwin R, Lee T, Young VB, Parameswaran N, McCabe LR. Colitis-induced bone loss is gender dependent and associated with increased inflammation. Inflamm Bowel Dis. 2013;19(8):1586\u201397.","journal-title":"Inflamm Bowel Dis"},{"issue":"6","key":"273_CR43","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S1074-7613(03)00326-1","volume":"19","author":"AJ Ashcroft","year":"2003","unstructured":"Ashcroft AJ, Cruickshank SM, Croucher PI, Perry MJ, Rollinson S, Lippitt JM, et al. Colonic Dendritic Cells, Intestinal Inflammation, and T Cell-Mediated Bone Destruction Are Modulated by Recombinant Osteoprotegerin. Immunity. 2003;19(6):849\u201361.","journal-title":"Immunity"},{"issue":"2","key":"273_CR44","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1093\/ibd\/izab174","volume":"28","author":"A Al Saedi","year":"2022","unstructured":"Al Saedi A, Sharma S, Bani Hassan E, Chen L, Ghasem-Zadeh A, Hassanzadeganroudsari M, et al. Characterization of Skeletal Phenotype and Associated Mechanisms With Chronic Intestinal Inflammation in the Winnie Mouse Model of Spontaneous Chronic Colitis. Inflamm Bowel Dis. 2022;28(2):259\u201372.","journal-title":"Inflamm Bowel Dis"},{"key":"273_CR45","unstructured":"Sharma S, Debruin D, Devereaux J, Nurgali K, Hayes A, Duque G. Advancements in inflammation parallels myopenia in winnie mice model of spontaneous chronic colitis. bioRxiv. 2024;2024.11.20.624215."},{"key":"273_CR46","doi-asserted-by":"crossref","unstructured":"Yang C, Merlin D. Unveiling colitis: a journey through the dextran sodium sulfate-induced model. Inflamm Bowel Dis. 2024;30(5):844\u201353.","DOI":"10.1093\/ibd\/izad312"},{"issue":"4","key":"273_CR47","doi-asserted-by":"publisher","first-page":"279","DOI":"10.4196\/kjpp.2014.18.4.279","volume":"18","author":"PK Randhawa","year":"2014","unstructured":"Randhawa PK, Singh K, Singh N, Jaggi AS. A review on chemical-induced inflammatory bowel disease models in rodents. Korean J Physiol Pharmacol. 2014;18(4):279\u201388.","journal-title":"Korean J Physiol Pharmacol"},{"issue":"33","key":"273_CR48","doi-asserted-by":"publisher","first-page":"6016","DOI":"10.3748\/wjg.v23.i33.6016","volume":"23","author":"DD Eichele","year":"2017","unstructured":"Eichele DD, Kharbanda KK. Dextran sodium sulfate colitis murine model: An indispensable tool for advancing our understanding of inflammatory bowel diseases pathogenesis. World J Gastroenterol. 2017;23(33):6016\u201329.","journal-title":"World J Gastroenterol"},{"key":"273_CR49","doi-asserted-by":"crossref","unstructured":"Chassaing B, Aitken JD, Malleshappa M, Vijay-Kumar M. Dextran sulfate sodium (DSS)-induced colitis in mice. Curr Protoc Immunol. 2014;(SUPPL.104):15.25.1-15.25.14.","DOI":"10.1002\/0471142735.im1525s104"},{"key":"273_CR50","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1152\/ajpgi.00467.2004","volume":"288","author":"S Melgar","year":"2005","unstructured":"Melgar S, Karlsson A, Michae E, Karlsson A, Michae E. Acute colitis induced by dextran sulfate sodium progresses to chronicity in C57BL\/6 but not in BALB\/c mice: correlation between symptoms and inflammation. Am J Physiol Gastrointest Liver Physiol. 2005;288:1328\u201338.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"273_CR51","doi-asserted-by":"crossref","unstructured":"Hern\u00e1ndez-Chirlaque C, Aranda CJ, Oc\u00f3n B, Capit\u00e1n-Ca\u00f1adas F, Ortega-Gonz\u00e1lez M, Carrero JJ, et al. Germ-free and antibiotic-treated mice are highly susceptible to epithelial injury in DSS Colitis. J Crohn\u2019s Colitis. 2016;10(11):1324\u201335.","DOI":"10.1093\/ecco-jcc\/jjw096"},{"issue":"1","key":"273_CR52","doi-asserted-by":"publisher","first-page":"2297831","DOI":"10.1080\/19490976.2023.2297831","volume":"16","author":"JL Krause","year":"2024","unstructured":"Krause JL, Engelmann B, Schaepe SS, Rolle-Kampczyk U, Jehmlich N, Chang H-D, et al. DSS treatment does not affect murine colonic microbiota in absence of the host. Gut Microbes. 2024;16(1):2297831.","journal-title":"Gut Microbes"},{"issue":"3","key":"273_CR53","doi-asserted-by":"publisher","first-page":"e0264400","DOI":"10.1371\/journal.pone.0264400","volume":"17","author":"S Mukhopadhyay","year":"2022","unstructured":"Mukhopadhyay S, Saha S, Chakraborty S, Prasad P, Ghosh A, Aich P. Differential colitis susceptibility of Th1- and Th2-biased mice: A multi-omics approach. PLoS ONE. 2022;17(3):e0264400.","journal-title":"PLoS ONE"},{"issue":"4","key":"273_CR54","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.gastha.2024.01.016","volume":"3","author":"E Ikeda","year":"2024","unstructured":"Ikeda E, Yamaguchi M, Kawabata S. Gut Microbiota-mediated Alleviation of Dextran Sulfate Sodium-induced Colitis in Mice. Gastro Hep Adv. 2024;3(4):461\u201370.","journal-title":"Gastro Hep Adv"},{"issue":"6","key":"273_CR55","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1007\/s00223-021-00808-5","volume":"108","author":"S Rajput","year":"2021","unstructured":"Rajput S, Mehta P, Mittal M, Rajender S, Chattopadhyay N. Human Relevance of Preclinical Studies on the Skeletal Impact of Inflammatory Bowel Disease: A Systematic Review and Meta \u2013 Analysis. Calcif Tissue Int. 2021;108(6):708\u201324.","journal-title":"Calcif Tissue Int"},{"issue":"1","key":"273_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BSR20192317","volume":"40","author":"JS Luo","year":"2020","unstructured":"Luo JS, Zhao X, Yang Y. Effects of emodin on inflammatory bowel disease-related osteoporosis. Biosci Rep. 2020;40(1):BSR20192317.","journal-title":"Biosci Rep"},{"issue":"4","key":"273_CR57","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.jcmgh.2022.07.002","volume":"14","author":"CT Peek","year":"2022","unstructured":"Peek CT, Ford CA, Eichelberger KR, Jacobse J, Torres TP, Maseda D, et al. Intestinal Inflammation Promotes MDL-1(+) Osteoclast Precursor Expansion to Trigger Osteoclastogenesis and Bone Loss. Cell Mol Gastroenterol Hepatol. 2022;14(4):731\u201350.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"15","key":"273_CR58","doi-asserted-by":"publisher","first-page":"8304","DOI":"10.1111\/jcmm.15554","volume":"24","author":"L Ehlers","year":"2020","unstructured":"Ehlers L, Bannert K, Rohde S, Berlin P, Reiner J, Wiese M, et al. Preclinical insights into the gut-skeletal muscle axis in chronic gastrointestinal diseases. J Cell Mol Med. 2020;24(15):8304\u201314.","journal-title":"J Cell Mol Med"},{"issue":"14","key":"273_CR59","doi-asserted-by":"publisher","first-page":"8964","DOI":"10.1074\/jbc.M114.616516","volume":"290","author":"VM Radhakrishnan","year":"2015","unstructured":"Radhakrishnan VM, Kojs P, Ramalingam R, Midura-Kiela MT, Angeli P, Kiela PR, et al. Experimental colitis is associated with transcriptional inhibition of Na+\/Ca2+ exchanger isoform 1 (NCX1) expression by interferon \u03b3 in the renal distal convoluted tubules. J Biol Chem. 2015;290(14):8964\u201374.","journal-title":"J Biol Chem"},{"issue":"5","key":"273_CR60","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1136\/gut.46.5.695","volume":"46","author":"AB Ballinger","year":"2000","unstructured":"Ballinger AB, Azooz O, El-Haj T, Poole S, Farthing MJ. Growth failure occurs through a decrease in insulin-like growth factor 1 which is independent of undernutrition in a rat model of colitis. Gut. 2000;46(5):694\u2013700.","journal-title":"Gut"},{"key":"273_CR61","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3389\/fimmu.2017.00501","volume":"8","author":"L Hanyang","year":"2017","unstructured":"Hanyang L, Xuanzhe L, Xuyang C, Yujia Q, Jiarong F, Jun S, et al. Application of Zebrafish Models in Inflammatory Bowel Disease. Front Immunol. 2017;8:501.","journal-title":"Front Immunol"},{"issue":"suppl2","key":"273_CR62","doi-asserted-by":"publisher","first-page":"S132","DOI":"10.1097\/00054725-200810001-00064","volume":"14","author":"MB Grisham","year":"2008","unstructured":"Grisham MB. Do different animal models of IBD serve different purposes? Inflamm Bowel Dis. 2008;14(suppl2):S132\u20133.","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"273_CR63","doi-asserted-by":"publisher","first-page":"G135","DOI":"10.1152\/ajpgi.90462.2008","volume":"296","author":"DV Ostanin","year":"2009","unstructured":"Ostanin DV, Bao J, Koboziev I, Gray L, Robinson-Jackson SA, Kosloski-Davidson M, et al. T cell transfer model of chronic colitis: concepts, considerations, and tricks of the trade. Am J Physiol Gastrointest Liver Physiol. 2009;296(2):G135\u201346.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"2","key":"273_CR64","first-page":"90","volume":"64","author":"AC Ericsson","year":"2014","unstructured":"Ericsson AC, Hagan CE, Davis DJ, Franklin CL. Segmented filamentous bacteria: commensal microbes with potential effects on research. Comp Med. 2014;64(2):90\u20138.","journal-title":"Comp Med"},{"issue":"7","key":"273_CR65","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1136\/gutjnl-2014-306947","volume":"64","author":"T Ciucci","year":"2015","unstructured":"Ciucci T, Ib\u00e1\u00f1ez L, Boucoiran A, Birgy-Barelli E, P\u00e8ne J, Abou-Ezzi G, et al. Bone marrow Th17 TNF\u03b1 cells induce osteoclast differentiation, and link bone destruction to IBD. Gut. 2015;64(7):1072\u201381.","journal-title":"Gut"},{"issue":"640","key":"273_CR66","first-page":"1","volume":"6","author":"A Wakkach","year":"2015","unstructured":"Wakkach A, Rouleau M, Blin-Wakkach C. Osteoimmune interactions in inflammatory bowel disease: Central role of bone marrow Th17 TNF\u03b1 cells in osteoclastogenesis. Front Immunol. 2015;6(640):1\u20136.","journal-title":"Front Immunol"},{"issue":"1","key":"273_CR67","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41577-022-00746-9","volume":"23","author":"KHG Mills","year":"2023","unstructured":"Mills KHG. IL-17 and IL-17-producing cells in protection versus pathology. Nat Rev Immunol. 2023;23(1):38\u201354.","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"273_CR68","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.immuni.2011.03.018","volume":"34","author":"A Chaudhry","year":"2011","unstructured":"Chaudhry A, Samstein RM, Treuting P, Liang Y, Pils MC, Heinrich J-M, et al. Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation. Immunity. 2011;34(4):566\u201378.","journal-title":"Immunity"},{"key":"273_CR69","doi-asserted-by":"crossref","unstructured":"Xie Wqing, He M, Yu D, jie, Wu Y, xiang, Wang X hua, Lv S, et al. Mouse models of sarcopenia: classification and evaluation. J Cachexia Sarcopenia Muscle. 2021;12(3):538\u201354.","DOI":"10.1002\/jcsm.12709"},{"issue":"1","key":"273_CR70","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/mi.2010.61","volume":"4","author":"JG Fox","year":"2011","unstructured":"Fox JG, Ge Z, Whary MT, Erdman SE, Horwitz BH. Helicobacter hepaticus infection in mice: models for understanding lower bowel inflammation and cancer. Mucosal Immunol. 2011;4(1):22\u201330.","journal-title":"Mucosal Immunol"},{"issue":"2","key":"273_CR71","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1093\/ibd\/izx014","volume":"24","author":"C Reinoso Webb","year":"2018","unstructured":"Reinoso Webb C, den Bakker H, Koboziev I, Jones-Hall Y, Rao Kottapalli K, Ostanin D, et al. Differential Susceptibility to T Cell-Induced Colitis in Mice: Role of the Intestinal Microbiota. Inflamm Bowel Dis. 2018;24(2):361\u201379.","journal-title":"Inflamm Bowel Dis"},{"issue":"8","key":"273_CR72","doi-asserted-by":"publisher","first-page":"e70783","DOI":"10.1371\/journal.pone.0070783","volume":"8","author":"I Yang","year":"2013","unstructured":"Yang I, Eibach D, Kops F, Brenneke B, Woltemate S, Schulze J, et al. Intestinal microbiota composition of interleukin-10 deficient C57BL\/6J mice and susceptibility to Helicobacter hepaticus-induced colitis. PLoS ONE. 2013;8(8):e70783.","journal-title":"PLoS ONE"},{"issue":"3","key":"273_CR73","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1053\/j.gastro.2004.06.013","volume":"127","author":"R Dresner-Pollak","year":"2004","unstructured":"Dresner-Pollak R, Gelb N, Rachmilewitz D, Karmeli F, Weinreb M. Interleukin 10-deficient mice develop osteopenia, decreased bone formation, and mechanical fragility of long bones. Gastroenterology. 2004;127(3):792\u2013801.","journal-title":"Gastroenterology"},{"issue":"5","key":"273_CR74","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1097\/00054725-200409000-00009","volume":"10","author":"SL Cohen","year":"2004","unstructured":"Cohen SL, Moore AM, Ward WE. Interleukin-10 knockout mouse: a model for studying bone metabolism during intestinal inflammation. Inflamm Bowel Dis. 2004;10(5):557\u201363.","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"273_CR75","doi-asserted-by":"publisher","first-page":"100881","DOI":"10.1016\/j.xcrm.2022.100881","volume":"4","author":"J Guo","year":"2023","unstructured":"Guo J, Wang F, Hu Y, Luo Y, Wei Y, Xu K, et al. Exosome-based bone-targeting drug delivery alleviates impaired osteoblastic bone formation and bone loss in inflammatory bowel diseases. Cell Rep Med. 2023;4(1):100881.","journal-title":"Cell Rep Med"},{"issue":"2","key":"273_CR76","doi-asserted-by":"publisher","first-page":"G191","DOI":"10.1152\/ajpgi.00496.2010","volume":"300","author":"FK Ghishan","year":"2011","unstructured":"Ghishan FK, Kiela PR. Advances in the understanding of mineral and bone metabolism in inflammatory bowel diseases. Am J Physiol Gastrointest Liver Physiol. 2011;300(2):G191\u2013201.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"1","key":"273_CR77","doi-asserted-by":"publisher","first-page":"385","DOI":"10.4049\/jimmunol.160.1.385","volume":"160","author":"NV Contractor","year":"1998","unstructured":"Contractor NV, Bassiri H, Reya T, Park AY, Baumgart DC, Wasik MA, et al. Lymphoid hyperplasia, autoimmunity, and compromised intestinal intraepithelial lymphocyte development in colitis-free gnotobiotic IL-2-deficient mice. J Immunol. 1998;160(1):385\u201394.","journal-title":"J Immunol"},{"key":"273_CR78","doi-asserted-by":"crossref","unstructured":"Sadlack B, Merz H, Schorle H, Schimpl A, Feller AC, Horak I. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell. 1993;75(2):253\u201361.","DOI":"10.1016\/0092-8674(93)80067-O"},{"issue":"6","key":"273_CR79","first-page":"G1461","volume":"276","author":"M Schultz","year":"1999","unstructured":"Schultz M, Tonkonogy SL, Sellon RK, Veltkamp C, Godfrey VL, Kwon J, et al. IL-2-deficient mice raised under germfree conditions develop delayed mild focal intestinal inflammation. Am J Physiol. 1999;276(6):G1461\u201372.","journal-title":"Am J Physiol"},{"key":"273_CR80","unstructured":"Madsen KL, Jijon H. IL-10 and IL-2 Knockout Mice BT - Cytokine Knockouts. In: Fantuzzi G, editor. Totowa, NJ: Humana Press; 2003;237\u201351."},{"issue":"3","key":"273_CR81","doi-asserted-by":"publisher","first-page":"0440","DOI":"10.1371\/journal.pmed.0050054","volume":"5","author":"CK Heazlewood","year":"2008","unstructured":"Heazlewood CK, Cook MC, Eri R, Price GR, Tauro SB, Taupin D, et al. Aberrant mucin assembly in mice causes endoplasmic reticulum stress and spontaneous inflammation resembling ulcerative colitis. PLoS Med. 2008;5(3):e54.","journal-title":"PLoS Med"},{"key":"273_CR82","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/978-1-61779-527-5_19","volume":"844","author":"R Eri","year":"2012","unstructured":"Eri R, McGuckin MA, Wadley R. T cell transfer model of colitis: a great tool to assess the contribution of T cells in chronic intestinal inflammation. Methods Mol Biol. 2012;844:261\u201375.","journal-title":"Methods Mol Biol"},{"issue":"3","key":"273_CR83","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/mi.2010.74","volume":"4","author":"RD Eri","year":"2011","unstructured":"Eri RD, Adams RJ, Tran TV, Tong H, Das I, Roche DK, et al. An intestinal epithelial defect conferring ER stress results in inflammation involving both innate and adaptive immunity. Mucosal Immunol. 2011;4(3):354\u201364.","journal-title":"Mucosal Immunol"},{"issue":"6","key":"273_CR84","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1016\/j.ajpath.2018.02.007","volume":"188","author":"A Tawiah","year":"2018","unstructured":"Tawiah A, Cornick S, Moreau F, Gorman H, Kumar M, Tiwari S, et al. High MUC2 Mucin Expression and Misfolding Induce Cellular Stress, Reactive Oxygen Production, and Apoptosis in Goblet Cells. Am J Pathol. 2018;188(6):1354\u201373.","journal-title":"Am J Pathol"},{"key":"273_CR85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms21082972","volume":"21","author":"S Santis","year":"2020","unstructured":"De Santis S, Verna G, Serino G, Cavalcanti E, Liso M, Dicarlo M, et al. Winnie- APC Min \/+ Mice: A Spontaneous Model of Colitis-Associated Colorectal Cancer Combining Genetics and Inflammation. Int J Mol Sci. 2020;21(8):2972.","journal-title":"Int J Mol Sci"},{"key":"273_CR86","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1093\/ibd\/izaf006","volume":"31","author":"M Chieppa","year":"2025","unstructured":"Chieppa M, Santis S, De VG. Winnie Mice: A Chronic and Progressive Model of Ulcerative Colitis. Inflamm Bowel Dis. 2025;31:1158\u201367.","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"273_CR87","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2021.1900996","volume":"13","author":"R Wang","year":"2021","unstructured":"Wang R, Moniruzzaman M, Wong KY, Wiid P, Harding A, Giri R, et al. Gut microbiota shape the inflammatory response in mice with an epithelial defect. Gut Microbes. 2021;13(1):1\u201318.","journal-title":"Gut Microbes"},{"issue":"6","key":"273_CR88","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1007\/s10753-022-01706-0","volume":"45","author":"A Tal\u00e0","year":"2022","unstructured":"Tal\u00e0 A, Guerra F, Resta SC, Calcagnile M, Barca A, Tredici SM, et al. Phenotyping of Fecal Microbiota of Winnie, a Rodent Model of Spontaneous Chronic Colitis, Reveals Specific Metabolic, Genotoxic, and Pro-inflammatory Properties. Inflammation. 2022;45(6):2477\u201397.","journal-title":"Inflammation"},{"key":"273_CR89","doi-asserted-by":"crossref","unstructured":"Liu A, Lv H, Wang H, Yang H, Li Y, Qian J. Aging increases the severity of colitis and the related changes to the gut barrier and gut microbiota in humans and mice. Journals Gerontol Ser A. 2020;75(7):1284\u201392.","DOI":"10.1093\/gerona\/glz263"},{"key":"273_CR90","doi-asserted-by":"publisher","first-page":"6005225","DOI":"10.1155\/mi\/6005225","volume":"2025","author":"Z Wu","year":"2025","unstructured":"Wu Z, Yang J, Zhu Y, Li J, Xu K, Li Y, et al. Causal Associations of Inflammatory Cytokines With Osteosarcopenia: Insights From Mendelian Randomization and Single Cell Analysis. Mediators Inflamm. 2025;2025:6005225.","journal-title":"Mediators Inflamm"},{"issue":"110778","key":"273_CR91","first-page":"1","volume":"129","author":"A Al Saedi","year":"2019","unstructured":"Al Saedi A, Sharma S, Summers MA, Nurgali K, Duque G. The multiple faces of tryptophan in bone biology. Exp Gerontol. 2020;129:110778.","journal-title":"Exp Gerontol"},{"issue":"3","key":"273_CR92","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/nm.2098","volume":"16","author":"BS Yadav","year":"2010","unstructured":"Yadav BS, Suresh PS, Liu XS, Lu X, Li Z, et al. Inhibition of gut-derived serotonin synthesis: a potential bone anabolic treatment. Nat Med. 2010;16(3):308\u201312.","journal-title":"Nat Med"},{"issue":"8","key":"273_CR93","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/nrgastro.2013.105","volume":"10","author":"GM Mawe","year":"2013","unstructured":"Mawe GM, Hoffman JM. Serotonin signalling in the gut-functions, dysfunctions and therapeutic targets. Nat Rev Gastroenterol Hepatol. 2013;10(8):473\u201386.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"9","key":"273_CR94","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1002\/jbmr.439","volume":"26","author":"H Inose","year":"2011","unstructured":"Inose H, Zhou B, Yadav VK, Guo XE, Karsenty G, Ducy P. Efficacy of serotonin inhibition in mouse models of bone loss. J Bone Min Res. 2011;26(9):2002\u201311.","journal-title":"J Bone Min Res"},{"issue":"5","key":"273_CR95","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.cell.2008.09.059","volume":"135","author":"RJ-H Yadav","year":"2008","unstructured":"Yadav RJ-H, Suda N, Tanaka KF, Gingrich JA, Sch\u00fctz G, et al. Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum. Cell. 2008;135(5):825\u201337.","journal-title":"Cell"},{"issue":"1","key":"273_CR96","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1053\/j.gastro.2006.11.002","volume":"132","author":"MD Gershon","year":"2007","unstructured":"Gershon MD, Tack J. The Serotonin Signaling System: From Basic Understanding To Drug Development for Functional GI Disorders. Gastroenterology. 2007;132(1):397\u2013414.","journal-title":"Gastroenterology"},{"issue":"1","key":"273_CR97","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1083\/jcb.201006123","volume":"191","author":"P Ducy","year":"2010","unstructured":"Ducy P, Karsenty G. The two faces of serotonin in bone biology. J Cell Biol. 2010;191(1):7\u201313.","journal-title":"J Cell Biol"},{"issue":"5","key":"273_CR98","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1093\/ibd\/izy016","volume":"24","author":"R Stavely","year":"2018","unstructured":"Stavely R, Fraser S, Sharma S, Rahman AA, Stojanovska V, Sakkal S, et al. The Onset and Progression of Chronic Colitis Parallels Increased Mucosal Serotonin Release via Enterochromaffin Cell Hyperplasia and Downregulation of the Serotonin Reuptake Transporter. Inflamm Bowel Dis. 2018;24(5):1021\u201334.","journal-title":"Inflamm Bowel Dis"},{"key":"273_CR99","doi-asserted-by":"crossref","unstructured":"Linden DR, Foley KF, Mcquoid C, Simpson J, Sharkey KA, Mawe GM. Serotonin transporter function and expression are reduced in mice with TNBS-induced colitis. Neurogastroenterol Motil. 2005;17(4):565\u201374.","DOI":"10.1111\/j.1365-2982.2005.00673.x"},{"issue":"1","key":"273_CR100","first-page":"G207","volume":"285","author":"DR Linden","year":"2015","unstructured":"Linden DR, Chen J-X, Gershon MD, Sharkey KA, Mawe GM. Serotonin availability is increased in mucosa of guinea pigs with TNBS-induced colitis. Am J Physiol Liver Physiol. 2003;285(1):G207\u201316.","journal-title":"Am J Physiol Liver Physiol"},{"key":"273_CR101","doi-asserted-by":"crossref","unstructured":"Zhang N, Zhai L, Wong RMY, Cui C, Law S-W, Chow SK-H, et al. Harnessing immunomodulation to combat sarcopenia: current insights and possible approaches. Immun Ageing. 2024;21(1):55.","DOI":"10.1186\/s12979-024-00458-9"},{"issue":"5","key":"273_CR102","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1053\/j.gastro.2009.08.041","volume":"137","author":"JE Ghia","year":"2009","unstructured":"Ghia JE, Li N, Wang H, Collins M, Deng Y, El-Sharkawy RT, et al. Serotonin Has a Key Role in Pathogenesis of Experimental Colitis. Gastroenterology. 2009;137(5):1649\u201360.","journal-title":"Gastroenterology"},{"key":"273_CR103","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.phrs.2018.07.018","volume":"140","author":"B Lavoie","year":"2019","unstructured":"Lavoie B, Roberts JA, Haag MM, Spohn SN, Margolis KG, Sharkey KA, et al. Gut-derived serotonin contributes to bone deficits in colitis. Pharmacol Res. 2019;140:75\u201384.","journal-title":"Pharmacol Res"},{"issue":"8","key":"273_CR104","doi-asserted-by":"publisher","first-page":"103136","DOI":"10.1016\/j.autrev.2022.103136","volume":"21","author":"C Triantos","year":"2022","unstructured":"Triantos C, Aggeletopoulou I, Mantzaris GJ, Mouzaki \u0391. Molecular basis of vitamin D action in inflammatory bowel disease. Autoimmun Rev. 2022;21(8):103136.","journal-title":"Autoimmun Rev"},{"issue":"6","key":"273_CR105","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1210\/en.2010-0089","volume":"151","author":"V Lagishetty","year":"2010","unstructured":"Lagishetty V, Misharin AV, Liu NQ, Lisse TS, Chun RF, Ouyang Y, et al. Vitamin D deficiency in mice impairs colonic antibacterial activity and predisposes to colitis. Endocrinology. 2010;151(6):2423\u201332.","journal-title":"Endocrinology"},{"key":"273_CR106","doi-asserted-by":"publisher","first-page":"950465","DOI":"10.3389\/fimmu.2023.950465","volume":"14","author":"A Ghaseminejad-Raeini","year":"2023","unstructured":"Ghaseminejad-Raeini A, Ghaderi A, Sharafi A, Nematollahi-Sani B, Moossavi M, Derakhshani A, et al. Immunomodulatory actions of vitamin D in various immune-related disorders: a comprehensive review. Front Immunol. 2023;14:950465.","journal-title":"Front Immunol"},{"issue":"12","key":"273_CR107","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1016\/j.imbio.2012.07.018","volume":"217","author":"H Korf","year":"2012","unstructured":"Korf H, Wenes M, Stijlemans B, Takiishi T, Robert S, Miani M, et al. 1,25-Dihydroxyvitamin D3 curtails the inflammatory and T cell stimulatory capacity of macrophages through an IL-10-dependent mechanism. Immunobiology. 2012;217(12):1292\u2013300.","journal-title":"Immunobiology"},{"issue":"12","key":"273_CR108","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1210\/me.2003-0281","volume":"17","author":"M Froicu","year":"2003","unstructured":"Froicu M, Weaver V, Wynn TA, McDowell MA, Welsh JE, Cantorna MT. A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases. Mol Endocrinol. 2003;17(12):2386\u201392.","journal-title":"Mol Endocrinol"},{"issue":"10","key":"273_CR109","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.3945\/jn.113.180794","volume":"143","author":"JH Ooi","year":"2013","unstructured":"Ooi JH, Li Y, Rogers CJ, Cantorna MT. Vitamin D Regulates the Gut Microbiome and Protects Mice from Dextran Sodium Sulfate\u2013Induced Colitis1, 2, 3. J Nutr. 2013;143(10):1679\u201386.","journal-title":"J Nutr"},{"issue":"1","key":"273_CR110","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13099-019-0291-z","volume":"11","author":"W Zhu","year":"2019","unstructured":"Zhu W, Yan J, Zhi C, Zhou Q, Yuan X. 1,25(OH)2D3 deficiency-induced gut microbial dysbiosis degrades the colonic mucus barrier in Cyp27b1 knockout mouse model. Gut Pathog. 2019;11(1):8.","journal-title":"Gut Pathog"},{"key":"273_CR111","doi-asserted-by":"crossref","unstructured":"Garcia PM, Moore J, Kahan D, Hong MY. Effects of vitamin D supplementation on inflammation, colonic cell kinetics, and microbiota in colitis: a review. Molecules. 2020;25(10):2300.","DOI":"10.3390\/molecules25102300"},{"key":"273_CR112","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/jcm11195715","volume":"11","author":"A Szymczak-Tomczak","year":"2022","unstructured":"Szymczak-Tomczak A, Ratajczak AE, Kaczmarek-Ry\u015b M, Hryhorowicz S, Rychter AM, Zawada A, et al. Pleiotropic Effects of Vitamin D in Patients with Inflammatory Bowel Diseases. J Clin Med. 2022;11:19.","journal-title":"J Clin Med"},{"issue":"1","key":"273_CR113","first-page":"49","volume":"8","author":"T Dadaei","year":"2015","unstructured":"Dadaei T, Safapoor MH, Asadzadeh Aghdaei H, Balaii H, Pourhoseingholi MA, Naderi N, et al. Effect of vitamin D3 supplementation on TNF-\u03b1 serum level and disease activity index in Iranian IBD patients. Gastroenterol Hepatol bed bench. 2015;8(1):49\u201355.","journal-title":"Gastroenterol Hepatol bed bench"},{"issue":"1","key":"273_CR114","doi-asserted-by":"publisher","first-page":"11511","DOI":"10.1038\/s41598-018-29759-y","volume":"8","author":"S Ghaly","year":"2018","unstructured":"Ghaly S, Kaakoush NO, Lloyd F, McGonigle T, Mok D, Baird A, et al. High Dose Vitamin D supplementation alters faecal microbiome and predisposes mice to more severe colitis. Sci Rep. 2018;8(1):11511.","journal-title":"Sci Rep"},{"issue":"1","key":"273_CR115","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1152\/ajpgi.00065.2013","volume":"305","author":"CB Larmonier","year":"2013","unstructured":"Larmonier CB, McFadden R-MT, Hill FM, Schreiner R, Ramalingam R, Besselsen DG, et al. High vitamin D3 diet administered during active colitis negatively affects bone metabolism in an adoptive T cell transfer model. Am J Physiol Gastrointest Liver Physiol. 2013;305(1):35\u201346.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"9","key":"273_CR116","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1210\/en.2014-1016","volume":"155","author":"CM Girgis","year":"2014","unstructured":"Girgis CM, Mokbel N, Cha KM, Houweling PJ, Abboud M, Fraser DR, et al. The vitamin D receptor (VDR) is expressed in skeletal muscle of male mice and modulates 25-hydroxyvitamin D (25OHD) uptake in myofibers. Endocrinology. 2014;155(9):3227\u201337.","journal-title":"Endocrinology"},{"issue":"2","key":"273_CR117","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00223-012-9645-y","volume":"92","author":"L Ceglia","year":"2013","unstructured":"Ceglia L, Harris SS. Vitamin D and its role in skeletal muscle. Calcif Tissue Int. 2013;92(2):151\u201362.","journal-title":"Calcif Tissue Int"},{"issue":"2","key":"273_CR118","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.ecl.2010.02.007","volume":"39","author":"JW Pike","year":"2010","unstructured":"Pike JW, Meyer MB. The vitamin D receptor: new paradigms for the regulation of gene expression by 1,25-dihydroxyvitamin D(3). Endocrinol Metab Clin North Am. 2010;39(2):255\u201369.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"273_CR119","doi-asserted-by":"publisher","first-page":"660498","DOI":"10.3389\/fphys.2021.660498","volume":"12","author":"CM Latham","year":"2021","unstructured":"Latham CM, Brightwell CR, Keeble AR, Munson BD, Thomas NT, Zagzoog AM, et al. Vitamin D Promotes Skeletal Muscle Regeneration and Mitochondrial Health. Front Physiol. 2021;12:660498.","journal-title":"Front Physiol"},{"issue":"12","key":"273_CR120","doi-asserted-by":"publisher","first-page":"5138","DOI":"10.1210\/en.2003-0502","volume":"144","author":"I Endo","year":"2003","unstructured":"Endo I, Inoue D, Mitsui T, Umaki Y, Akaike M, Yoshizawa T, et al. Deletion of vitamin D receptor gene in mice results in abnormal skeletal muscle development with deregulated expression of myoregulatory transcription factors. Endocrinology. 2003;144(12):5138\u201344.","journal-title":"Endocrinology"},{"key":"273_CR121","doi-asserted-by":"crossref","unstructured":"Salles J, Chanet A, Giraudet C, Patrac V, Pierre P, Jourdan M et al. 1,25(OH) 2 -vitamin D 3 enhances the stimulating effect of leucine and insulin on protein synthesis rate through Akt\/PKB and mTOR mediated pathways in murine C2C12 skeletal myotubes. Mol Nutr Food Res. 2013;57(12):2137\u201346.","DOI":"10.1002\/mnfr.201300074"},{"key":"273_CR122","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.jsbmb.2015.05.012","volume":"152","author":"M Bhat","year":"2015","unstructured":"Bhat M, Ismail A. Vitamin D treatment protects against and reverses oxidative stress induced muscle proteolysis. J Steroid Biochem Mol Biol. 2015;152:171\u20139.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"8","key":"273_CR123","doi-asserted-by":"publisher","first-page":"2976","DOI":"10.1210\/en.2011-0159","volume":"152","author":"LA Garcia","year":"2011","unstructured":"Garcia LA, King KK, Ferrini MG, Norris KC, Artaza JN. 1,25(OH)2vitamin D3 stimulates myogenic differentiation by inhibiting cell proliferation and modulating the expression of promyogenic growth factors and myostatin in C2C12 skeletal muscle cells. Endocrinology. 2011;152(8):2976\u201386.","journal-title":"Endocrinology"},{"issue":"5","key":"273_CR124","first-page":"1021","volume":"22","author":"K Wada","year":"2009","unstructured":"Wada K, Tanaka H, Maeda K, Inoue T, Noda E, Amano R, et al. Vitamin D receptor expression is associated with colon cancer in ulcerative colitis. Oncol Rep. 2009;22(5):1021\u20135.","journal-title":"Oncol Rep"},{"issue":"4","key":"273_CR125","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s00198-019-05234-w","volume":"31","author":"AA van Bodegraven","year":"2020","unstructured":"van Bodegraven AA, Bravenboer N. Perspective on skeletal health in inflammatory bowel disease. Osteoporos Int. 2020;31(4):637\u201346.","journal-title":"Osteoporos Int"},{"key":"273_CR126","doi-asserted-by":"crossref","unstructured":"Van Langenberg GP, Della, Hill B, Zacharewicz E, Gibson PR, Russell AP. Delving into disability in Crohn\u2019s disease: Dysregulation of molecular pathways may explain skeletal muscle loss in Crohn\u2019s disease. J Crohn\u2019s Colitis. 2014;8(7):626\u201334.","DOI":"10.1016\/j.crohns.2013.11.024"},{"issue":"656","key":"273_CR127","first-page":"1","volume":"13","author":"A Dhaliwal","year":"2021","unstructured":"Dhaliwal A, Quinlan JI, Overthrow K, Greig C, Lord JM, Armstrong MJ, et al. Sarcopenia in inflammatory bowel disease: A narrative overview. Nutrients. 2021;13(2):656.","journal-title":"Nutrients"},{"issue":"2","key":"273_CR128","doi-asserted-by":"publisher","first-page":"162","DOI":"10.5217\/ir.2023.00090","volume":"22","author":"PB Neelam","year":"2024","unstructured":"Neelam PB, Pal R, Gupta P, Singh AK, Shah J, Mandavdhare HS, et al. Sarcopenia is common in ulcerative colitis and correlates with disease activity. Intest Res. 2024;22(2):162\u201371.","journal-title":"Intest Res"},{"key":"273_CR129","doi-asserted-by":"crossref","unstructured":"Davies A, Nixon A, Muhammed R, Tsintzas K, Kirkham S, Stephens FB, et al. Reduced skeletal muscle protein balance in paediatric Crohn\u2019s disease. Clin Nutr. 2020;39(4):1250\u20137.","DOI":"10.1016\/j.clnu.2019.05.017"},{"issue":"2","key":"273_CR130","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.crohns.2013.07.006","volume":"8","author":"DR van Langenberg","year":"2014","unstructured":"van Langenberg DR, Della Gatta P, Warmington SA, Kidgell DJ, Gibson PR, Russell AP. Objectively measured muscle fatigue in Crohn\u2019s disease: correlation with self-reported fatigue and associated factors for clinical application. J Crohns Colitis. 2014;8(2):137\u201346.","journal-title":"J Crohns Colitis"},{"issue":"3","key":"273_CR131","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1093\/jcag\/gwy039","volume":"2","author":"MS Shajib","year":"2019","unstructured":"Shajib MS, Chauhan U, Adeeb S, Chetty Y, Armstrong D, Halder SLS, et al. Characterization of Serotonin Signaling Components in Patients with Inflammatory Bowel Disease. J Can Assoc Gastroenterol. 2019;2(3):132\u201340.","journal-title":"J Can Assoc Gastroenterol"},{"issue":"7","key":"273_CR132","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1053\/j.gastro.2004.03.013","volume":"126","author":"MD Coates","year":"2004","unstructured":"Coates MD, Mahoney CR, Linden DR, Sampson JE, Chen J, Blaszyk H, et al. Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome. Gastroenterology. 2004;126(7):1657\u201364.","journal-title":"Gastroenterology"},{"issue":"9","key":"273_CR133","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1097\/MIB.0000000000000150","volume":"20","author":"D Guseva","year":"2014","unstructured":"Guseva D, Holst K, Kaune B, Meier M, Keubler L, Glage S, et al. Serotonin 5-HT7 receptor is critically involved in acute and chronic inflammation of the gastrointestinal tract. Inflamm Bowel Dis. 2014;20(9):1516\u201329.","journal-title":"Inflamm Bowel Dis"},{"key":"273_CR134","doi-asserted-by":"crossref","unstructured":"Bertrand PP. Real-time detection of serotonin release from enterochromaffin cells of the guinea-pig ileum. Neurogastroenterol Motil. 2004;16(5):511\u20134.","DOI":"10.1111\/j.1365-2982.2004.00572.x"},{"issue":"6","key":"273_CR135","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1053\/j.gastro.2017.08.028","volume":"153","author":"S Nikolaus","year":"2017","unstructured":"Nikolaus S, Schulte B, Al-Massad N, Thieme F, Schulte DM, Bethge J, et al. Increased Tryptophan Metabolism Is Associated With Activity of Inflammatory Bowel Diseases. Gastroenterology. 2017;153(6):1504\u2013e15162.","journal-title":"Gastroenterology"},{"key":"273_CR136","doi-asserted-by":"crossref","unstructured":"Koopman N, Katsavelis D, Hove AS, Ten, Brul S, Jonge WJ, De. Seppen J multifaceted role serotonin intestinal homeost. Int J Mol Sci. 2021;22(17):9487.","DOI":"10.3390\/ijms22179487"},{"issue":"5","key":"273_CR137","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/molecules27051680","volume":"27","author":"T Guzel","year":"2022","unstructured":"Guzel T, Mirowska-Guzel D. The Role of Serotonin Neurotransmission in Gastrointestinal Tract and Pharmacotherapy. Molecules. 2022;27(5):1680.","journal-title":"Molecules"},{"issue":"10","key":"273_CR138","doi-asserted-by":"publisher","first-page":"C836","DOI":"10.1152\/ajpcell.00053.2016","volume":"310","author":"M Schlittler","year":"2016","unstructured":"Schlittler M, Goiny M, Agudelo LZ, Venckunas T, Brazaitis M, Skurvydas A, et al. Endurance exercise increases skeletal muscle kynurenine aminotransferases and plasma kynurenic acid in humans. Am J Physiol Cell Physiol. 2016;310(10):C836\u201340.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"1","key":"273_CR139","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.cell.2014.07.051","volume":"159","author":"LZ Agudelo","year":"2014","unstructured":"Agudelo LZ, Femen\u00eda T, Orhan F, Porsmyr-Palmertz M, Goiny M, Martinez-Redondo V, et al. Skeletal muscle PGC-1\u03b11 modulates kynurenine metabolism and mediates resilience to stress-induced depression. Cell. 2014;159(1):33\u201345.","journal-title":"Cell"},{"issue":"2","key":"273_CR140","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1359\/jbmr.090721","volume":"25","author":"UI M\u00f6dder","year":"2010","unstructured":"M\u00f6dder UI, Achenbach SJ, Amin S, Riggs BL, Melton LJ, Khosla S. Relation of serum serotonin levels to bone density and structural parameters in women. J Bone Min Res. 2010;25(2):415\u201322.","journal-title":"J Bone Min Res"},{"issue":"2","key":"273_CR141","doi-asserted-by":"publisher","first-page":"47","DOI":"10.15436\/2380-5595.15.626","volume":"1","author":"M Carsote","year":"2015","unstructured":"Carsote M, Valea A. Circulating Serotonin as Bone Remodelling Marker in Women. J Gynecol Neonatal Biol. 2015;1(2):47\u20139.","journal-title":"J Gynecol Neonatal Biol"},{"issue":"7","key":"273_CR142","doi-asserted-by":"publisher","first-page":"2902","DOI":"10.1210\/jc.2012-4174","volume":"98","author":"JS Walsh","year":"2013","unstructured":"Walsh JS, Newell-Price JD, DeBono M, Adaway J, Keevil B, Eastell R. Circulating serotonin and bone density, structure, and turnover in carcinoid syndrome. J Clin Endocrinol Metab. 2013;98(7):2902\u20137.","journal-title":"J Clin Endocrinol Metab 2013\/04\/30"},{"key":"273_CR143","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/978-3-319-66653-2_7","volume":"1033","author":"FA Sylvester","year":"2017","unstructured":"Sylvester FA. Inflammatory Bowel Disease: Effects on Bone and Mechanisms. Adv Exp Med Biol. 2017;1033:133\u201350.","journal-title":"Adv Exp Med Biol"},{"key":"273_CR144","doi-asserted-by":"publisher","first-page":"3712","DOI":"10.1111\/jcmm.15075","volume":"24","author":"C Han","year":"2020","unstructured":"Han C, Guo L, Sheng Y, Yang Y, Wang J, Gu Y, et al. FoxO1 regulates TLR4 \/ MyD88 \/ MD2-NF- \u03ba B inflammatory signalling in mucosal barrier injury of inflammatory bowel disease. J Cell Mol Med. 2020;24:3712\u201323.","journal-title":"J Cell Mol Med"},{"key":"273_CR145","doi-asserted-by":"crossref","unstructured":"Hausmann J, Kubesch A, Amiri M, Filmann N, Blumenstein I. Conflicting evidence exists regarding the relationship between vitamin D levels, disease activity, and inflammatory markers. J Clin Med. 2019;8.","DOI":"10.3390\/jcm8091319"},{"key":"273_CR146","doi-asserted-by":"crossref","unstructured":"Bendix M, Dige A, J\u00f8rgensen SP, Dahlerup JF, Bibby BM, Deleuran B, et al. Seven weeks of high-dose Vitamin D treatment reduces the need for infliximab dose-escalation and decreases inflammatory markers in Crohn\u2019s disease during one-year follow-up. Nutrients. 2021;13(4):1083.","DOI":"10.3390\/nu13041083"},{"key":"273_CR147","doi-asserted-by":"crossref","unstructured":"Ananthakrishnan AN, Khalili H, Higuchi LM, Bao Y, Korzenik JR, Giovannucci EL, et al. Higher predicted vitamin D status is associated with reduced risk of Crohn\u2019s disease. Gastroenterology. 2012;142(3):482\u20139.","DOI":"10.1053\/j.gastro.2011.11.040"},{"issue":"2","key":"273_CR148","first-page":"127","volume":"10","author":"H Pappa","year":"2014","unstructured":"Pappa H. Vitamin D deficiency and supplementation in patients with IBD. Gastroenterol Hepatol. 2014;10(2):127\u20139.","journal-title":"Gastroenterol Hepatol"},{"key":"273_CR149","doi-asserted-by":"crossref","unstructured":"Li Y, Zhao P, Jiang B, Liu K, Zhang L, Wang H et al. Modulation of the vitamin D\/vitamin D receptor system in osteoporosis pathogenesis: insights and therapeutic approaches. J Orthop Surg Res. 2023;18(1):860.","DOI":"10.1186\/s13018-023-04320-4"},{"issue":"5","key":"273_CR150","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.crohns.2012.06.003","volume":"7","author":"SF Bakker","year":"2013","unstructured":"Bakker SF, Dik VK, Witte BI, Lips P, Roos JC, Van Bodegraven AA. Increase in bone mineral density in strictly treated Crohn\u2019s disease patients with concomitant calcium and vitamin D supplementation. J Crohn\u2019s Colitis. 2013;7(5):377\u201384.","journal-title":"J Crohn\u2019s Colitis"},{"key":"273_CR151","doi-asserted-by":"crossref","unstructured":"Melek J, Sakuraba A. Efficacy and safety of medical therapy for low bone mineral density in patients with inflammatory bowel disease: a meta-analysis and systematic review. Clin Gastroenterol Hepatol. 2014;12(1):32\u201344.e5.","DOI":"10.1016\/j.cgh.2013.08.024"},{"issue":"8","key":"273_CR152","doi-asserted-by":"publisher","first-page":"3438","DOI":"10.1210\/jc.2013-1631","volume":"98","author":"A Tsampalieros","year":"2013","unstructured":"Tsampalieros A, Lam CKL, Spencer JC, Thayu M, Shults J, Zemel BS, et al. Long-term inflammation and glucocorticoid therapy impair skeletal modeling during growth in childhood Crohn disease. J Clin Endocrinol Metab. 2013;98(8):3438\u201345.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"273_CR153","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.3390\/nu11051019","volume":"11","author":"J Fletcher","year":"2019","unstructured":"Fletcher J, Cooper SC, Ghosh S, Hewison M. The Role of Vitamin D in Inflammatory Bowel Disease: Mechanism to Management. Nutrients. 2019;11(5):1019.","journal-title":"Nutrients"},{"key":"273_CR154","doi-asserted-by":"publisher","first-page":"1498293","DOI":"10.1155\/2022\/1498293","volume":"2022","author":"Y Yin","year":"2022","unstructured":"Yin Y, Lu X, Li Z, Liu S, Shao L, Cao L, et al. Risk Factors for Worsening of Bone Loss in Patients Newly Diagnosed with Inflammatory Bowel Disease. Gastroenterol Res Pract. 2022;2022:1498293.","journal-title":"Gastroenterol Res Pract"},{"key":"273_CR155","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.3390\/nu13041378","volume":"13","author":"F Palmese","year":"2021","unstructured":"Palmese F, Del TR, Giulia DM, Cataleta P, Maria GS, Domenicali M. Sarcopenia and Vitamin D Deficiency in Patients with Crohn \u2019 s Disease: Pathological Conditions That Should Be Linked Together. Nutrients. 2021;13:1378.","journal-title":"Nutrients"},{"key":"273_CR156","doi-asserted-by":"crossref","unstructured":"Grunbaum A, Holcroft C, Heilpern D, Gladman S, Burstein B, Menard M, et al. Dynamics of vitamin D in patients with mild or inactive inflammatory bowel disease and their families. Nutr J. 2013;12(1):145.","DOI":"10.1186\/1475-2891-12-145"},{"key":"273_CR157","doi-asserted-by":"crossref","unstructured":"Rigterink T, Appleton L, Day AS. Vitamin D therapy in children with inflammatory bowel disease: a systematic review. World J Clin Pediatr. 2019;8(1):1\u201314.","DOI":"10.5409\/wjcp.v8.i1.1"},{"issue":"4","key":"273_CR158","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1097\/MIB.0000000000001047","volume":"23","author":"O Hradsky","year":"2017","unstructured":"Hradsky O, Soucek O, Maratova K, Matyskova J, Copova I, Zarubova K, et al. Supplementation with 2000 IU of Cholecalciferol Is Associated with Improvement of Trabecular Bone Mineral Density and Muscle Power in Pediatric Patients with IBD. Inflamm Bowel Dis. 2017;23(4):514\u201323.","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"273_CR159","doi-asserted-by":"publisher","first-page":"e13033","DOI":"10.1002\/jgh3.13033","volume":"8","author":"PB Neelam","year":"2024","unstructured":"Neelam PB, Sharma A, Sharma V. Sarcopenia and frailty in inflammatory bowel disease: Emerging concepts and evidence. JGH Open. 2024;8(1):e13033.","journal-title":"JGH Open"},{"issue":"2","key":"273_CR160","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3904\/kjim.2024.359","volume":"40","author":"YJ Yang","year":"2025","unstructured":"Yang YJ, Jeon SR. Metabolic musculoskeletal disorders in patients with inflammatory bowel disease. Korean J Intern Med. 2025;40(2):181\u201395.","journal-title":"Korean J Intern Med"},{"key":"273_CR161","doi-asserted-by":"crossref","unstructured":"Katz S. and Weinerman S. The elderly inflammatory bowel disease patient and osteoporosis. Aging health. 2012;8(1):31\u201342.","DOI":"10.2217\/ahe.11.86"},{"key":"273_CR162","doi-asserted-by":"crossref","unstructured":"Levine AE, Mark D, Smith L, Zheng HB, Suskind DL. Pharmacologic management of monogenic and very early onset inflammatory bowel diseases. Pharmaceutics. 2023;15(3):969.","DOI":"10.3390\/pharmaceutics15030969"},{"issue":"1","key":"273_CR163","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41413-023-00264-x","volume":"11","author":"Z Lyu","year":"2023","unstructured":"Xiao YT, Yan WH, Cao Y, Yan JK, Cai W. Neutralization of IL-6 and TNF-\u03b1 ameliorates intestinal permeability in DSS-induced colitis. Cytokine. 2016;83:189\u201392.","journal-title":"Bone Reseac"},{"issue":"7","key":"273_CR164","doi-asserted-by":"publisher","first-page":"2630","DOI":"10.1210\/jc.2014-4152","volume":"100","author":"LM Griffin","year":"2015","unstructured":"Griffin LM, Thayu M, Baldassano RN, DeBoer MD, Zemel BS, Denburg MR, et al. Improvements in bone density and structure during anti-TNF-\u03b1 therapy in pediatric Crohn\u2019s disease. J Clin Endocrinol Metab. 2015;100(7):2630\u20139.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"273_CR165","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/ibd.20069","volume":"13","author":"TD Walters","year":"2006","unstructured":"Walters TD, Gilman AR, Griffiths AM. Linear Growth Improves during Infliximab Therapy in Children with Chronically Active Severe Crohn\u2019s Disease. Inflamm Bowel Dis. 2007;13(4):424\u201330.","journal-title":"Inflamm Bowel Dis"},{"issue":"8","key":"273_CR166","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1111\/j.1365-2036.2004.02097.x","volume":"20","author":"BM Ryan","year":"2004","unstructured":"Ryan BM, Russel MGVM, Schurgers L, Wichers M, Sijbrandij J, Stockbrugger RW, et al. Effect of antitumour necrosis factor-\u03b1 therapy on bone turnover in patients with active Crohn\u2019s disease: A prospective study. Aliment Pharmacol Ther. 2004;20(8):851\u20137.","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"273_CR167","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1210\/jc.2017-01916","volume":"103","author":"MD DeBoer","year":"2018","unstructured":"DeBoer MD, Lee AM, Herbert K, Long J, Thayu M, Griffin LM, et al. Increases in IGF-1 After Anti-TNF-\u03b1 Therapy Are Associated With Bone and Muscle Accrual in Pediatric Crohn Disease. J Clin Endocrinol Metab. 2018;103(3):936\u201345.","journal-title":"J Clin Endocrinol Metab"},{"key":"273_CR168","doi-asserted-by":"publisher","first-page":"116523","DOI":"10.1016\/j.biopha.2024.116523","volume":"174","author":"T Chen","year":"2024","unstructured":"Chen T, Ai G, Liang G, Zeng L, Zhao D, Liu J, et al. Mitigation of inflammatory bowel disease-related osteoporosis by oxyberberine: Insights into the RANKL\/NF-\u03baB signaling pathway. Biomed Pharmacother. 2024;174:116523.","journal-title":"Biomed Pharmacother"},{"issue":"February","key":"273_CR169","first-page":"1","volume":"10","author":"Y Wang","year":"2023","unstructured":"Wang Y, Yao D, He Y, He Q, Li Y. Earlier anti-TNF therapy reduces the risk of malnutrition associated with alterations in body composition in patients with Crohn\u2019s disease. Front Nutr. 2023;10:1114758.","journal-title":"Front Nutr"},{"key":"273_CR170","doi-asserted-by":"crossref","unstructured":"Liu E, Aslam N, Nigam G, Limdi JK. Tofacitinib and newer JAK inhibitors in inflammatory bowel disease-where we are and where we are going. Drugs Context. 2022;11:2021-11-4.","DOI":"10.7573\/dic.2021-11-4"},{"issue":"1","key":"273_CR171","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1136\/flgastro-2023-102400","volume":"15","author":"S Honap","year":"2023","unstructured":"Honap S, Agorogianni A, Colwill MJ, Mehta SK, Donovan F, Pollok R, et al. JAK inhibitors for inflammatory bowel disease: recent advances. Frontline Gastroenterol. 2023;15(1):59\u201369.","journal-title":"Frontline Gastroenterol"},{"key":"273_CR172","doi-asserted-by":"crossref","unstructured":"Pippis EJ, Yacyshyn BR. Clinical and mechanistic characteristics of current JAK inhibitors in IBD. Inflamm Bowel Dis. 2021;27(10):1674\u201383.","DOI":"10.1093\/ibd\/izaa318"},{"issue":"11","key":"273_CR173","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1080\/21645515.2018.1461297","volume":"14","author":"I Catalan-Serra","year":"2018","unstructured":"Catalan-Serra I, Brenna \u00d8. Immunotherapy in inflammatory bowel disease: Novel and emerging treatments. Hum Vaccin Immunother. 2018;14(11):2597\u2013611.","journal-title":"Hum Vaccin Immunother"},{"issue":"9","key":"273_CR174","doi-asserted-by":"publisher","first-page":"4732","DOI":"10.4049\/jimmunol.169.9.4732","volume":"169","author":"H Kitaura","year":"2002","unstructured":"Kitaura H, Nagata N, Fujimura Y, Hotokezaka H, Yoshida N, Nakayama K. Effect of IL-12 on TNF-alpha-mediated osteoclast formation in bone marrow cells: apoptosis mediated by Fas\/Fas ligand interaction. J Immunol. 2002;169(9):4732\u20138.","journal-title":"J Immunol"},{"issue":"5","key":"273_CR175","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/j.bone.2009.07.079","volume":"45","author":"M Yoshimatsu","year":"2009","unstructured":"Yoshimatsu M, Kitaura H, Fujimura Y, Eguchi T, Kohara H, Morita Y, et al. IL-12 inhibits TNF-alpha induced osteoclastogenesis via a T cell-independent mechanism in vivo. Bone. 2009;45(5):1010\u20136.","journal-title":"Bone"},{"issue":"5","key":"273_CR176","doi-asserted-by":"publisher","first-page":"R96","DOI":"10.1186\/ar2297","volume":"9","author":"T Yago","year":"2007","unstructured":"Yago T, Nanke Y, Kawamoto M, Furuya T, Kobashigawa T, Kamatani N, et al. IL-23 induces human osteoclastogenesis via IL-17 in vitro, and anti-IL-23 antibody attenuates collagen-induced arthritis in rats. Arthritis Res Ther. 2007;9(5):R96.","journal-title":"Arthritis Res Ther"},{"issue":"10","key":"273_CR177","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1002\/eji.200838192","volume":"38","author":"L Chen","year":"2008","unstructured":"Chen L, Wei X-Q, Evans B, Jiang W, Aeschlimann D. IL-23 promotes osteoclast formation by up-regulation of receptor activator of NF-kappaB (RANK) expression in myeloid precursor cells. Eur J Immunol. 2008;38(10):2845\u201354.","journal-title":"Eur J Immunol"},{"key":"273_CR178","doi-asserted-by":"crossref","unstructured":"Fanizza J, D\u2019Amico F, Lusetti F, Fasulo E, Allocca M, Furfaro F, et al. The role of IL-23 inhibitors in Crohn\u2019s disease. J Clin Med. 2023;13(1).","DOI":"10.3390\/jcm13010224"},{"key":"273_CR179","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/j.1749-6632.2009.05070.x","volume":"1182","author":"M Elliott","year":"2009","unstructured":"Elliott M, Benson J, Blank M, Brodmerkel C, Baker D, Sharples KR, et al. Ustekinumab: lessons learned from targeting interleukin-12\/23p40 in immune-mediated diseases. Ann N Y Acad Sci. 2009;1182:97\u2013110.","journal-title":"Ann N Y Acad Sci"},{"key":"273_CR180","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.3389\/fmicb.2020.01405","volume":"11","author":"A Khafipour","year":"2020","unstructured":"Khafipour A, Eissa N, Munyaka PM, Rabbi MF, Kapoor K, Kermarrec L, et al. Denosumab Regulates Gut Microbiota Composition and Cytokines in Dinitrobenzene Sulfonic Acid (DNBS)-Experimental Colitis. Front Microbiol. 2020;11:1405.","journal-title":"Front Microbiol"},{"issue":"5","key":"273_CR181","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1007\/s00198-017-3919-1","volume":"28","author":"MR McClung","year":"2017","unstructured":"McClung MR, Wagman RB, Miller PD, Wang A, Lewiecki EM. Observations following discontinuation of long-term denosumab therapy. Osteoporos Int. 2017;28(5):1723\u201332.","journal-title":"Osteoporos Int"},{"key":"273_CR182","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.bone.2016.10.007","volume":"96","author":"J Delgado-Calle","year":"2017","unstructured":"Delgado-Calle J, Sato AY, Bellido T. Role and mechanism of action of sclerostin in bone. Bone. 2017;96:29\u201337.","journal-title":"Bone"},{"issue":"10","key":"273_CR183","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1359\/jbmr.090403","volume":"24","author":"A Eddleston","year":"2009","unstructured":"Eddleston A, Marenzana M, Moore AR, Stephens P, Muzylak M, Marshall D, et al. A short treatment with an antibody to sclerostin can inhibit bone loss in an ongoing model of colitis. J Bone Min Res. 2009;24(10):1662\u201371.","journal-title":"J Bone Min Res"},{"issue":"5\u20136","key":"273_CR184","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1007\/s10354-019-00721-5","volume":"170","author":"K Kerschan-Schindl","year":"2020","unstructured":"Kerschan-Schindl K. Romosozumab: a novel bone anabolic treatment option for osteoporosis? Wien Med Wochenschr. 2020;170(5\u20136):124\u201331.","journal-title":"Wien Med Wochenschr"},{"issue":"9","key":"273_CR185","doi-asserted-by":"publisher","first-page":"4848","DOI":"10.1096\/fj.201800178R","volume":"32","author":"SA Narayanan","year":"2018","unstructured":"Narayanan SA, Metzger CE, Bloomfield SA, Zawieja DC. Inflammation-induced lymphatic architecture and bone turnover changes are ameliorated by irisin treatment in chronic inflammatory bowel disease. FASEB J. 2018;32(9):4848\u201361.","journal-title":"FASEB J"},{"key":"273_CR186","doi-asserted-by":"crossref","unstructured":"Al-Araimi A, Al Kharusi A, Bani Oraba A, Al-Maney MM, Al Sinawi S, Al-Haddabi I, et al. Deletion of SOCS2 reduces post-colitis fibrosis via alteration of the TGF\u03b2 Pathway. Int J Mol Sci. 2020;21.","DOI":"10.3390\/ijms21093073"},{"key":"273_CR187","doi-asserted-by":"crossref","unstructured":"Dobie R, MacRae VE, Pass C, Milne EM, Ahmed SF, Farquharson C. Suppressor of cytokine signaling 2 (Socs2) deletion protects bone health of mice with DSS-induced inflammatory bowel disease. Dis Model Mech. 2018;11(1):dmm028456.","DOI":"10.1242\/dmm.028456"},{"key":"273_CR188","doi-asserted-by":"publisher","first-page":"112239","DOI":"10.1016\/j.biopha.2021.112239","volume":"144","author":"LG Guijarro","year":"2021","unstructured":"Guijarro LG, Cano-Mart\u00ednez D, Toledo-Lobo MV, Salinas PS, Chaparro M, G\u00f3mez-Lahoz AM, et al. Relationship between IGF-1 and body weight in inflammatory bowel diseases: Cellular and molecular mechanisms involved. Biomed Pharmacother. 2021;144:112239.","journal-title":"Biomed Pharmacother"},{"key":"273_CR189","doi-asserted-by":"crossref","unstructured":"He J, Ren W, Wang W, Han W, Jiang L, Zhang D, et al. Exosomal targeting and its potential clinical application. Drug Deliv Transl Res. 2022;12(10):2385\u2013402.","DOI":"10.1007\/s13346-021-01087-1"},{"key":"273_CR190","doi-asserted-by":"crossref","unstructured":"Saleem M, Shahzad KA, Marryum M, Singh S, Zhou Q, Du S, et al. Exosome-based therapies for inflammatory disorders: a review of recent advances. Stem Cell Res Ther. 2024;15(1):477.","DOI":"10.1186\/s13287-024-04107-2"},{"key":"273_CR191","doi-asserted-by":"crossref","unstructured":"Huang X, Zhang S, Wang Z. Therapeutic potential of extracellular vesicles in inflammatory diseases. Extracell Vesicle. 2025;5:100058.","DOI":"10.1016\/j.vesic.2024.100058"},{"key":"273_CR192","doi-asserted-by":"publisher","first-page":"3893","DOI":"10.2147\/IJN.S370784","volume":"17","author":"D-F Li","year":"2022","unstructured":"Li D-F, Yang M-F, Xu J, Xu H-M, Zhu M-Z, Liang Y-J, et al. Extracellular Vesicles: The Next Generation Theranostic Nanomedicine for Inflammatory Bowel Disease. Int J Nanomed. 2022;17:3893\u2013911.","journal-title":"Int J Nanomed"},{"key":"273_CR193","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.aninu.2021.11.005","volume":"8","author":"M Akhtar","year":"2022","unstructured":"Akhtar M, Chen Y, Ma Z, Zhang X, Shi D, Khan JA, et al. Gut microbiota-derived short chain fatty acids are potential mediators in gut inflammation. Anim Nutr. 2022;8:350\u201360.","journal-title":"Anim Nutr"},{"key":"273_CR194","doi-asserted-by":"crossref","unstructured":"Shin Y, Han S, Kwon J, Ju S, Choi TG, Kang I, et al. Roles of short-chain fatty acids in inflammatory bowel disease. Nutrients. 2023;15(20):4466.","DOI":"10.3390\/nu15204466"},{"key":"273_CR195","doi-asserted-by":"crossref","unstructured":"Chu X, Xing H, Chao M, Xie P, Jiang L. Gut microbiota modulation in osteoporosis: probiotics, prebiotics, and natural compounds. Metabolites. 2025;15(5):301.","DOI":"10.3390\/metabo15050301"},{"issue":"2","key":"273_CR196","doi-asserted-by":"publisher","first-page":"438","DOI":"10.14336\/AD.2019.0523","volume":"11","author":"K Ding","year":"2020","unstructured":"Ding K, Hua F, Ding W. Gut Microbiome and Osteoporosis. Aging Dis. 2020;11(2):438\u201347.","journal-title":"Aging Dis"},{"key":"273_CR197","doi-asserted-by":"crossref","unstructured":"Jakubczyk D, Leszczy\u0144ska K, G\u00f3rska S. The effectiveness of probiotics in the treatment of inflammatory bowel disease (IBD)\u2014a critical review. Nutrients. 2020;12(7):1973.","DOI":"10.3390\/nu12071973"},{"key":"273_CR198","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/978-3-319-66653-2_11","volume":"1033","author":"JD Schepper","year":"2017","unstructured":"Schepper JD, Irwin R, Kang J, Dagenais K, Lemon T, Shinouskis A, et al. Probiotics in Gut-Bone Signaling. Adv Exp Med Biol. 2017;1033:225\u201347.","journal-title":"Adv Exp Med Biol"},{"key":"273_CR199","doi-asserted-by":"crossref","unstructured":"Collins FL, Rios-Arce ND, Schepper JD, Jones AD, Schaefer L, Britton RA, et al. Beneficial effects of Lactobacillus reuteri 6475 on bone density in male mice is dependent on lymphocytes. Sci Rep. 2019;9(1):14708.","DOI":"10.1038\/s41598-019-51293-8"},{"issue":"8","key":"273_CR200","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1002\/jcp.24340","volume":"228","author":"LR McCabe","year":"2013","unstructured":"McCabe LR, Irwin R, Schaefer L, Britton RA. Probiotic use decreases intestinal inflammation and increases bone density in healthy male but not female mice. J Cell Physiol. 2013;228(8):1793\u20138.","journal-title":"J Cell Physiol"},{"issue":"7","key":"273_CR201","doi-asserted-by":"publisher","first-page":"e0134050","DOI":"10.1371\/journal.pone.0134050","volume":"10","author":"D Srutkova","year":"2015","unstructured":"Srutkova D, Schwarzer M, Hudcovic T, Zakostelska Z, Drab V, Spanova A, et al. Bifidobacterium longum CCM 7952 Promotes Epithelial Barrier Function and Prevents Acute DSS-Induced Colitis in Strictly Strain-Specific Manner. PLoS ONE. 2015;10(7):e0134050.","journal-title":"PLoS ONE"},{"issue":"7","key":"273_CR202","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1017\/S000711451400169X","volume":"112","author":"R Mariman","year":"2014","unstructured":"Mariman R, Kremer B, Koning F, Nagelkerken L. The probiotic mixture VSL#3 mediates both pro- and anti-inflammatory responses in bone marrow-derived dendritic cells from C57BL\/6 and BALB\/c mice. Br J Nutr. 2014;112(7):1088\u201397.","journal-title":"Br J Nutr"},{"issue":"4","key":"273_CR203","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/nu13041115","volume":"13","author":"SJ van Krimpen","year":"2021","unstructured":"van Krimpen SJ, Jansen FAC, Ottenheim VL, Belzer C, van der Ende M, van Norren K. The Effects of Pro-, Pre-, and Synbiotics on Muscle Wasting, a Systematic Review-Gut Permeability as Potential Treatment Target. Nutrients. 2021;13(4):1115.","journal-title":"Nutrients"},{"issue":"4","key":"273_CR204","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41575-019-0258-z","volume":"17","author":"A Lavelle","year":"2020","unstructured":"Lavelle A, Sokol H. Gut microbiota-derived metabolites as key actors in inflammatory bowel disease. Nat Rev Gastroenterol Hepatol. 2020;17(4):223\u201337.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"8","key":"273_CR205","doi-asserted-by":"publisher","first-page":"595","DOI":"10.3390\/cells14080595","volume":"14","author":"G Urbani","year":"2025","unstructured":"Urbani G, Rondini E, Distrutti E, Marchian\u00f2 S, Biagioli M, Fiorucci S. Phenotyping the Chemical Communications of the Intestinal Microbiota and the Host: Secondary Bile Acids as Postbiotics. Cells. 2025;14(8):595.","journal-title":"Cells"},{"issue":"1","key":"273_CR206","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/nyas.13414","volume":"1401","author":"B-J Guo","year":"2017","unstructured":"Guo B-J, Bian Z-X, Qiu H-C, Wang Y-T, Wang Y. Biological and clinical implications of herbal medicine and natural products for the treatment of inflammatory bowel disease. Ann N Y Acad Sci. 2017;1401(1):37\u201348.","journal-title":"Ann N Y Acad Sci"},{"issue":"8","key":"273_CR207","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1177\/1535370218769420","volume":"243","author":"X Ge","year":"2018","unstructured":"Ge X, Chen Z, Xu Z, Lv F, Zhang K, Yang Y. The effects of dihydroartemisinin on inflammatory bowel disease-related bone loss in a rat model. Exp Biol Med. 2018;243(8):715\u201324.","journal-title":"Exp Biol Med"},{"key":"273_CR208","doi-asserted-by":"crossref","unstructured":"Long Z, Xiang W, Xiao W, Min Y, Qu F, Zhang B, et al. Advances in the study of artemisinin and its derivatives for the treatment of rheumatic skeletal disorders, autoimmune inflammatory diseases, and autoimmune disorders: a comprehensive review. Front Immunol. 2024;15:1432625.","DOI":"10.3389\/fimmu.2024.1432625"},{"issue":"13","key":"273_CR209","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.3748\/wjg.v28.i13.1315","volume":"28","author":"Y-L Zhang","year":"2022","unstructured":"Zhang Y-L, Chen Q, Zheng L, Zhang Z-W, Chen Y-J, Dai Y-C, et al. Jianpi Qingchang Bushen decoction improves inflammatory response and metabolic bone disorder in inflammatory bowel disease-induced bone loss. World J Gastroenterol. 2022;28(13):1315\u201328.","journal-title":"World J Gastroenterol"},{"issue":"21","key":"273_CR210","doi-asserted-by":"publisher","first-page":"6604","DOI":"10.3390\/molecules26216604","volume":"26","author":"R Cao","year":"2021","unstructured":"Cao R, Wu X, Guo H, Pan X, Huang R, Wang G, et al. Naringin Exhibited Therapeutic Effects against DSS-Induced Mice Ulcerative Colitis in Intestinal Barrier-Dependent Manner. Molecules. 2021;26(21):6604.","journal-title":"Molecules"},{"key":"273_CR211","first-page":"100068","volume":"2","author":"A Sharma","year":"2021","unstructured":"Sharma A, Bhardwaj P, Arya SK, Naringin. A potential natural product in the field of biomedical applications. Carbohydr Polym Technol Appl. 2021;2:100068.","journal-title":"Carbohydr Polym Technol Appl"},{"key":"273_CR212","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.abb.2018.05.011","volume":"650","author":"C Li","year":"2018","unstructured":"Li C, Zhang J, Lv F, Ge X, Li G. Naringin protects against bone loss in steroid-treated inflammatory bowel disease in a rat model. Arch Biochem Biophys. 2018;650:22\u20139.","journal-title":"Arch Biochem Biophys"},{"key":"273_CR213","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.cyto.2016.04.012","volume":"83","author":"Y-T Xiao","year":"2016","unstructured":"Lyu Z, Hu Y, Guo Y, Liu D. Modulation of bone remodeling by the gut microbiota: a new therapy for osteoporosis. Bone Reseac. 2023;11(1):31.","journal-title":"Cytokine"}],"container-title":["Laboratory Animal Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42826-026-00273-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42826-026-00273-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42826-026-00273-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T05:14:29Z","timestamp":1778735669000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s42826-026-00273-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,14]]},"references-count":213,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["273"],"URL":"https:\/\/doi.org\/10.1186\/s42826-026-00273-x","relation":{},"ISSN":["2233-7660"],"issn-type":[{"value":"2233-7660","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,14]]},"assertion":[{"value":"27 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The article has been updated","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The author declares no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17"}}